A Controlled Study of the Effectiveness of an Adaptive Closed-Loop Algorithm to Minimize Corticosteroid-Induced Stress Hyperglycemia in Type 1 Diabetes
暂无分享,去创建一个
W. Kenneth Ward | B. Wayne Bequette | Peter G. Jacobs | Joseph El Youssef | Jessica R. Castle | B. Bequette | W. Ward | J. Castle | J. Youssef | R. Massoud | D. Branigan | Matthew Breen | P. Jacobs | Deborah L. Branigan | Ryan G. Massoud | Matthew E. Breen
[1] W. Vach,et al. Evidence-based insulin treatment in type 1 diabetes mellitus. , 2009, Diabetes research and clinical practice.
[2] D. Greenhalgh. Wound healing and diabetes mellitus. , 2003, Clinics in plastic surgery.
[3] M. Falciglia. Causes and consequences of hyperglycemia in critical illness , 2007, Current opinion in clinical nutrition and metabolic care.
[4] J. Leahy,et al. Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .
[5] M. Davidson,et al. Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. , 1996, Metabolism: clinical and experimental.
[6] A. El-Jabali. Neural network modeling and control of type 1 diabetes mellitus , 2005, Bioprocess and biosystems engineering.
[7] C. Cobelli,et al. In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.
[8] Andrey V. Savkin,et al. Optimal H∞ insulin injection control for blood glucose regulation in diabetic patients , 2005, IEEE Trans. Biomed. Eng..
[9] Eyal Dassau,et al. Proposed Clinical Application for Tuning Fuzzy Logic Controller of artificial Pancreas Utilizing a Personalization Factor , 2010, Journal of diabetes science and technology.
[10] Thomas Desaive,et al. Validation of a model-based virtual trials method for tight glycemic control in intensive care , 2010, Biomedical engineering online.
[11] J. Geoffrey Chase,et al. Impact of glucocorticoids on insulin resistance in the critically ill , 2011, Comput. Methods Programs Biomed..
[12] E. Atlas,et al. MD-Logic Artificial Pancreas System: A Pilot Study in Adults with Type 1 Diabetes Mellitus Running Title: Closed-Loop System In Type 1 Diabetes , 2010 .
[13] R. Femat,et al. Theoretical blood glucose control in hyper- and hypoglycemic and exercise scenarios by means of an H(infinity) algorithm. , 2010, Journal of theoretical biology.
[14] L. Magni,et al. Model Predictive Control of Type 1 Diabetes: An in Silico Trial , 2007, Journal of diabetes science and technology.
[15] Jessica R Castle,et al. Continuous glucose monitoring in subjects with type 1 diabetes: improvement in accuracy by correcting for background current. , 2010, Diabetes technology & therapeutics.
[16] Konstantina S. Nikita,et al. An Insulin Infusion Advisory System Based on Autotuning Nonlinear Model-Predictive Control , 2011, IEEE Transactions on Biomedical Engineering.
[17] Christopher E. Hann,et al. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model , 2005, Comput. Methods Programs Biomed..
[18] Christopher E. Hann,et al. In Silico Simulation of Long-Term Type 1 Diabetes Glycemic Control Treatment Outcomes , 2008, Journal of diabetes science and technology.
[19] P. Schneiter,et al. Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans. , 1998, American journal of physiology. Endocrinology and metabolism.
[20] Janet M. Allen,et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies , 2011, BMJ : British Medical Journal.
[21] G. Ward,et al. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients , 1997, Diabetologia.
[22] W. Ward,et al. Factors Influencing the Effectiveness of Glucagon for Preventing Hypoglycemia , 2010, Journal of diabetes science and technology.
[23] L. King. Impaired wound healing in patients with diabetes. , 2001, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[24] Robert G. Sutherlin,et al. A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.
[25] S. Hadjadj,et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[26] M. Saul,et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[27] Roman Hovorka,et al. Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients. , 2010, Diabetes technology & therapeutics.
[28] L. Mandarino,et al. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.
[29] Steen Andreassen,et al. A model of the endogenous glucose balance incorporating the characteristics of glucose transporters , 2000, Comput. Methods Programs Biomed..
[30] Roman Hovorka,et al. In Silico Testing—Impact on the Progress of the Closed Loop Insulin Infusion for Critically Ill Patients Project , 2008, Journal of diabetes science and technology.
[31] W. Kenneth Ward,et al. Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.
[32] B. Walker,et al. Glucocorticoids and insulin resistance: old hormones, new targets. , 1999, Clinical science.
[33] Malgorzata E. Wilinska,et al. Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin , 2005, IEEE Transactions on Biomedical Engineering.
[34] E. Atlas,et al. MD-Logic Artificial Pancreas System , 2010, Diabetes Care.
[35] Christopher E. Hann,et al. Development of a Clinical Type 1 Diabetes Metabolic System Model and in Silico Simulation Tool , 2008, Journal of diabetes science and technology.
[36] C. Levetan. Effect of hyperglycemia on stroke outcomes. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[37] Eyal Dassau,et al. In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. , 2009, Diabetes technology & therapeutics.
[38] R. Hovorka,et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.